Magnetic resonance imaging of the liver: Assessing response to treatment

Ihab R Kamel, David A. Bluemke

Research output: Contribution to journalArticle

Abstract

Imaging plays a critical role in evaluating tumor response to treatment. Change in tumor size on cross-sectional imaging has been widely accepted and used to guide clinical decision making. Until recently, researchers used the World Health Organization (WHO) criteria to determine tumor response. A new set of criteria recently has been adopted by the WHO, the National Cancer Institute, and the European Organization for Research and Treatment of Cancer. These criteria, called the Response Evaluation Criteria in Solid Tumors (RECIST), attempt to unify response assessment of treated lesions. Magnetic resonance imaging plays an important role in evaluating treatment response to new therapies directed toward hepatic lesion treatment. In this article, we describe the new RECIST criteria and the role of magnetic resonance imaging in assessing tumor response. We also discuss the magnetic resonance imaging findings after surgical resection, liver transplantation, and tissue ablation techniques currently available for the management of patients with liver tumors.

Original languageEnglish (US)
Pages (from-to)191-200
Number of pages10
JournalTopics in Magnetic Resonance Imaging
Volume13
Issue number3
DOIs
StatePublished - Jun 2002

Fingerprint

Magnetic Resonance Imaging
Liver
Neoplasms
Therapeutics
Ablation Techniques
National Cancer Institute (U.S.)
Liver Transplantation
Research Personnel
Organizations
Research
Response Evaluation Criteria in Solid Tumors

Keywords

  • Liver tumors
  • Magnetic resonance imaging
  • Response criteria

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Magnetic resonance imaging of the liver : Assessing response to treatment. / Kamel, Ihab R; Bluemke, David A.

In: Topics in Magnetic Resonance Imaging, Vol. 13, No. 3, 06.2002, p. 191-200.

Research output: Contribution to journalArticle

@article{f7bf094a0727425ea9dad2e79c8ace47,
title = "Magnetic resonance imaging of the liver: Assessing response to treatment",
abstract = "Imaging plays a critical role in evaluating tumor response to treatment. Change in tumor size on cross-sectional imaging has been widely accepted and used to guide clinical decision making. Until recently, researchers used the World Health Organization (WHO) criteria to determine tumor response. A new set of criteria recently has been adopted by the WHO, the National Cancer Institute, and the European Organization for Research and Treatment of Cancer. These criteria, called the Response Evaluation Criteria in Solid Tumors (RECIST), attempt to unify response assessment of treated lesions. Magnetic resonance imaging plays an important role in evaluating treatment response to new therapies directed toward hepatic lesion treatment. In this article, we describe the new RECIST criteria and the role of magnetic resonance imaging in assessing tumor response. We also discuss the magnetic resonance imaging findings after surgical resection, liver transplantation, and tissue ablation techniques currently available for the management of patients with liver tumors.",
keywords = "Liver tumors, Magnetic resonance imaging, Response criteria",
author = "Kamel, {Ihab R} and Bluemke, {David A.}",
year = "2002",
month = "6",
doi = "10.1097/00002142-200206000-00006",
language = "English (US)",
volume = "13",
pages = "191--200",
journal = "Topics in Magnetic Resonance Imaging",
issn = "0899-3459",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Magnetic resonance imaging of the liver

T2 - Assessing response to treatment

AU - Kamel, Ihab R

AU - Bluemke, David A.

PY - 2002/6

Y1 - 2002/6

N2 - Imaging plays a critical role in evaluating tumor response to treatment. Change in tumor size on cross-sectional imaging has been widely accepted and used to guide clinical decision making. Until recently, researchers used the World Health Organization (WHO) criteria to determine tumor response. A new set of criteria recently has been adopted by the WHO, the National Cancer Institute, and the European Organization for Research and Treatment of Cancer. These criteria, called the Response Evaluation Criteria in Solid Tumors (RECIST), attempt to unify response assessment of treated lesions. Magnetic resonance imaging plays an important role in evaluating treatment response to new therapies directed toward hepatic lesion treatment. In this article, we describe the new RECIST criteria and the role of magnetic resonance imaging in assessing tumor response. We also discuss the magnetic resonance imaging findings after surgical resection, liver transplantation, and tissue ablation techniques currently available for the management of patients with liver tumors.

AB - Imaging plays a critical role in evaluating tumor response to treatment. Change in tumor size on cross-sectional imaging has been widely accepted and used to guide clinical decision making. Until recently, researchers used the World Health Organization (WHO) criteria to determine tumor response. A new set of criteria recently has been adopted by the WHO, the National Cancer Institute, and the European Organization for Research and Treatment of Cancer. These criteria, called the Response Evaluation Criteria in Solid Tumors (RECIST), attempt to unify response assessment of treated lesions. Magnetic resonance imaging plays an important role in evaluating treatment response to new therapies directed toward hepatic lesion treatment. In this article, we describe the new RECIST criteria and the role of magnetic resonance imaging in assessing tumor response. We also discuss the magnetic resonance imaging findings after surgical resection, liver transplantation, and tissue ablation techniques currently available for the management of patients with liver tumors.

KW - Liver tumors

KW - Magnetic resonance imaging

KW - Response criteria

UR - http://www.scopus.com/inward/record.url?scp=0036620263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036620263&partnerID=8YFLogxK

U2 - 10.1097/00002142-200206000-00006

DO - 10.1097/00002142-200206000-00006

M3 - Article

C2 - 12357082

AN - SCOPUS:0036620263

VL - 13

SP - 191

EP - 200

JO - Topics in Magnetic Resonance Imaging

JF - Topics in Magnetic Resonance Imaging

SN - 0899-3459

IS - 3

ER -